Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
What's unique about our program is that we treat every patient differently. We understand the biology that drives tumors, so we are involved in research to develop treatments that are specific to the individual tumor and the individual child."
- Mark Kieran, MD, PhD, Director, Pediatric Medical Neuro-Oncology
Cerebellar pilocytic astrocytoma is the most common type of low grade glioma, with a very high cure rate of 90 to 95 percent. Low grade gliomas are slow growing, less aggressive cancers of the brain or spine. Children cured of cerebellar pilocytic astrocytoma enjoy a quality of life better than most children who’ve had cancer. A child’s balance, strength and coordination may be compromised if there was damage to the cerebellum, but a child’s fertility and life expectancy should not be affected.
How Dana-Farber/Boston Children’s Cancer and Blood Disorders Center approaches cerebellar pilocytic astrocytoma
At Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, we utilize the expertise of both Boston Children's Hospital and Dana-Farber Cancer Institute to treat children and adolescents with all forms of cancer.
Specialists from Boston Children’s Hospital work closely with the experts at Dana-Farber Cancer Institute to ensure that every aspect of your child’s health is overseen before, during and after the treatment period. Our multidisciplinary approach is used at every step of care, including reading x-rays and MRI scans, interpreting the diagnosis and making clinical decisions. We can provide your child with expert diagnosis, treatment and care—as well as the benefits of some of the most advanced clinical and scientific research in the world.
In our Low Grade Glioma Program we take a multidisciplinary approach to researching and treating children with cerebellar pilocytic astrocytoma. Since many of our practicing physicians are also active researchers, your child will get the very best treatment available. Specialists in our program are involved in clinical research for personalized medicine drugs, which target specific parts of the tumor based on the person’s genes.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”